Antiseptic bathing products include a range of wipes, solutions and bath towels that are used in various hospital wards, especially Intensive Care Units (ICUs), surgical wards and maternity wards, to prevent infections by ensuring sanitation and basic hygiene. They are important for pre-operation bathing as well as for preventing surgical site infections.
Most antiseptic bathing products incorporate chlorhexidine gluconate (CHG), an active ingredient that immediately kills microbes on contact; it also binds cohesively with the skin and continues killing germs even after the skin makes contact with water.
The antiseptic bathing products market is moderately fragmented and sees variation in participation based on product types. Mergers and acquisitions are a common practice in the market as companies have sought to expand their market share; an example of this is Stryker Corporation’s 2016 acquisition of Sage Products.
Simultaneously, the market’s growth has also proved lucrative to major players from the healthcare and pharmaceutical industries and players such as Procter & Gamble, Air Liquide, Ecolab, etc. have a strong presence in the antiseptic bathing products market.
Some of the key players in the antiseptic bathing products market include Ecolab, Medline Industries, Becton Dickinson & Co., Reyanard Health Supplies, Procter & Gamble, 3M, Air Liquide, Colorox Company, Deko Industries, Stryker Corporation, Reckitt Benckiser, Tropical Naturals, HiCare Health and Molnlycke Healthcare.
Product innovations and launches have been a constant market phenomenon as manufacturers have sought to reduce infection risks posed by multi-drug resistant pathogens. Manufacturers have also increased their focus on solutions, towels and wipes made to clean wards and ICUs rather than those directly applied on skin due to shifting government regulations on direct CHG application.
Some recent product launches include 3M’s 3M Avagard antiseptic solution with moisturizer and 3M Science Cavilon CHG Bathing & Cleansing Towels, HiCare Health’s Eco Bath Wipe, Molnlycke Healthcare’s HiBiClens and HiBi Universal Bathing Systems (HUBS), and Stryker Corporation’s Sage 2% CHG Clothes.
Use of CHG solutions, towels and wipes during surgeries remains the primary focus area for manufacturers as patients are most vulnerable to infections during surgeries. Infection risks in maternity wards is another key area of research for the market.
Drivers of the Antiseptic Bathing Products Market
The increasing accessibility of healthcare in developing countries, the rise in aged populations in developing countries, an increase in recurring health conditions and the healthcare industry’s increasing capability to resolve health conditions via surgical interventions have been the major drivers of the antiseptic bathing products market.
Constraints for the Antiseptic Bathing Products Market
Shifting World Health Organisation (WHO) and government regulations and recommendations in certain countries have proved a challenge for the market. A major reason for these shifts has been that empirical evidence of the superiority of CHG over other anti-bacterial solutions hasn’t been found. Independent and academic R&D in this area is hence a key concern for manufacturers.
Impact of Covid-19
The Covid-19 pandemic has brought the healthcare sector into focus and led to spurt in sales of antiseptic bathing products. It has also raised public awareness about healthcare practices. These trends are likely to endure beyond the immediate crisis as well, leading to a favourable situation for the antiseptic bathing products market.
North America and Europe have been the largest regional segments for the antiseptic bathing products market. They have benefitted from high hospital admission rates, ageing populations and superior healthcare practices. Lack of price sensitivity by hospitals towards antiseptic bathing products in favour of high-quality products is also a prominent feature of these regional segments.
The East Asian and South Asian segments have witnessed the fastest market growth due to expansion in the healthcare industry in countries like China, India, Bangladesh and the Southeast Asian nations. However, East Asia’s developed countries, i.e. Japan, South Korea and Taiwan, exhibit trends closer to the European and North American markets. Latin America, Oceania and Middle East and Africa are other key regional segments.
The antiseptic bathing products market can be segmented based on the following:
The report covers exhaustive analysis on:
Regional analysis includes
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.